Want to collaborate with us?
Charlton Morris is a Talent Solutions business who offer search, contract, volume and employer branding solutions to the life science markets.Are you interested in featuring in our podcast series? Get in touch below.
How Has AI Revolutionised Diagnostics?
In this episode, CM Life Science Business Manager, Nathan Rigby, speaks with Erez Naaman, Co-Founder & CTO at Scopio Labs.
Prior to Scopio Labs, Erez was VP of Engineering & Business Development at OrCam, a leading Israeli high-tech start-up. He brings much of his insight from this experience to this discussion, as well as insight into the development of his current business, trends in AI and how he believes this affects the future of healthcare.
Scopio Labs uses full-field digital cell morphology to automate the analysis of tens of thousands of cells at a time – far more than any human can quantify, bringing dramatically earlier detection and diagnosis of cancers, infections, and other diseases. This technology expedites patients’ access to better care and life-saving treatments, with a key focus on digitizing microscopy and bringing it to the modern age. By providing access to rapid diagnostic tools for the first time. This system includes uniquely built-in computational power to enable AI at the user's fingertips - saving time, enabling collaboration, improving data safety and reducing the need for expensive hardware.
If you're interested in hearing more about Erez and his company or are fascinated by what AI brings to the future of the space, then be sure to have a listen.
To find out more about Nathan and his work in the diagnostic space, get in touch at nathan.rigby@lifesci-cm.com or connect on LinkedIn to chat.
Recommended.
-
26 January 2023Breaking Down Corporate Development.
In this live webinar, I welcomed two esteemed guests with over 20 years combined experience in corporate development to break down strategies and processes and discuss their insights. Click to watch the full recording.
-
18 January 2023How Has AI Revolutionised Diagnostics?
In this episode, we speak with Erez Naaman, Co-Founder & CTO at Scopio Labs, about what to introduction of AI means for the future of the diagnostics market.
-
11 January 2023Diversifying Diagnostics to Make a Difference.
In this episode, Nathan speaks with Richard Acton, former CSO at Cignpost Diagnostics, about transitioning a company from a COVID testing business to a health and wellness business.
Comments.